Company / Current Liabilities
IONIS PHARMACEUTICALS INC Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$781.6M
FY2025
5-year range
$240.6M / $781.6M
FY2021-FY2025
Trend
+152.7%
vs FY2024
Sector context
#29 of 213
Health Care
What the data says
IONIS PHARMACEUTICALS INC's current liabilities of $782M is higher than 86% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $134M in FY2016 to $782M in FY2025.
Based on SEC 10-K filings.
$782M in FY2025 with a 5-year CAGR of +6.0%. Top quartile in the Health Care sector.
Increased from $448M to $782M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
-50.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, current liabilities increased 152.7% year-over-year.
- Ranks #29 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $781.6M | +152.7% |
| FY2024 | $309.3M | -31.0% |
| FY2023 | $448.1M | +43.8% |
| FY2022 | $311.6M | +29.5% |
| FY2021 | $240.6M | -58.8% |
| FY2020 | $583.3M | +113.6% |
| FY2019 | $273.0M | -2.6% |
| FY2018 | $280.3M | +15.1% |
| FY2017 | $243.6M | +82.1% |
| FY2016 | $133.8M | -10.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026